Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Ismailos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|February 3, 2026
Cannabinoids and drug-drug pharmacokinetic interactions: Deciphering the risksParaskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 7, 2025
Optimising pirfenidone dosage regimens in idiopathic pulmonary fibrosis: towards a guide for personalised treatmentNastia Tsyplakova, Georgios Ismailos, Vangelis D Karalis
Respiratory Medicine|January 23, 2019
Microbiota and asthma: Clinical implicationsKonstantinos Katsoulis, Georgios Ismailos, Maria Kipourou, et al.
Lupus|March 24, 2022
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature reviewEfthymia Papadopoulou, Maria Saroglou, Georgios Ismailos, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease ExacerbationMaria Kipourou, Olga Begou, Katerina Manika, et al.
Journal of Inflammation (London, England)|May 21, 2010
Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusionMaria Saroglou, Stavros Tryfon, Georgios Ismailos, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|February 3, 2026
Cannabinoids and drug-drug pharmacokinetic interactions: Deciphering the risksParaskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 7, 2025
Optimising pirfenidone dosage regimens in idiopathic pulmonary fibrosis: towards a guide for personalised treatmentNastia Tsyplakova, Georgios Ismailos, Vangelis D Karalis
Respiratory Medicine|January 23, 2019
Microbiota and asthma: Clinical implicationsKonstantinos Katsoulis, Georgios Ismailos, Maria Kipourou, et al.
Lupus|March 24, 2022
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature reviewEfthymia Papadopoulou, Maria Saroglou, Georgios Ismailos, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease ExacerbationMaria Kipourou, Olga Begou, Katerina Manika, et al.
Journal of Inflammation (London, England)|May 21, 2010
Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusionMaria Saroglou, Stavros Tryfon, Georgios Ismailos, et al.
Pageof 1